Vatzia Eleni, Paudyal Basudev, Dema Barbara, Carr Brigid Veronica, Sedaghat-Rostami Ehsan, Gubbins Simon, Sharma Bhawna, Moorhouse Elliot, Morris Susan, Ulaszewska Marta, MacLoughlin Ronan, Salguero Francisco J, Gilbert Sarah C, Tchilian Elma
The Pirbright Institute, Pirbright, UK.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.
NPJ Vaccines. 2024 Oct 13;9(1):188. doi: 10.1038/s41541-024-00989-8.
Current influenza vaccines are strain-specific and require frequent updates to combat new strains, making a broadly protective influenza vaccine (BPIV) highly desirable. A promising strategy is to induce T-cell responses against internal proteins conserved across influenza strains. In this study, pH1N1 pre-exposed pigs were immunized by aerosol using viral vectored vaccines (ChAdOx2 and MVA) expressing matrix (M1) and nucleoprotein (NP). Following H3N2 challenge, all immunizations (M1, NP or NPM1) reduced lung pathology, but M1 alone offered the greatest protection. NP or NPM1 immunization induced both T-cell and antibody responses. M1 immunization generated no detectable antibodies but elicited M1-specific T-cell responses, suggesting T cell-mediated protection. Additionally, a single aerosol immunization with the ChAdOx vaccine encoding M1, NP and neuraminidase reduced lung pathology. These findings provide insights into BPIV development using a relevant large natural host, the pig.
目前的流感疫苗是针对特定毒株的,需要频繁更新以对抗新毒株,因此非常需要一种具有广泛保护作用的流感疫苗(BPIV)。一种有前景的策略是诱导针对流感毒株间保守的内部蛋白的T细胞反应。在本研究中,用表达基质蛋白(M1)和核蛋白(NP)的病毒载体疫苗(ChAdOx2和MVA)通过气溶胶对预先接触过pH1N1的猪进行免疫。在受到H3N2攻击后,所有免疫接种(M1、NP或NPM1)都减轻了肺部病理状况,但单独的M1提供了最大的保护。NP或NPM1免疫接种诱导了T细胞和抗体反应。M1免疫接种未产生可检测到的抗体,但引发了M1特异性T细胞反应,表明是T细胞介导的保护作用。此外,单次气溶胶免疫接种编码M1、NP和神经氨酸酶的ChAdOx疫苗可减轻肺部病理状况。这些发现为利用相关的大型天然宿主猪开发BPIV提供了见解。